Atormac
Neurology India
Open access journal indexed with Index Medicus
  Users online: 818  
 Home | Login 
  About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe Etcetera Contact  
Read this article

 


    Article Cited by others



Botulinum toxin treatment of hemifacial spasm and blepharospasm : objective response evaluation.

Thussu A, Barman C R, Prabhakar S

Year : 1999| Volume: 47| Issue : 3 | Page no: 206-9

   This article has been cited by
 
1 Blepharospasm and hemifacial spasm: Long-term treatment with botulinum toxin [Blefarospasmo y espasmo hemifacial: Tratamiento a largo plazo con toxina botulínica]
Gil Polo, C. and Rodríguez Sanz, M.F. and Berrocal Izquierdo, N. and Castrillo Sanz, A. and Gutiérrez Ríos, R. and Zamora García, M.I. and Mendoza Rodríguez, A. and Duarte García-Luis, J.
Neurologia. 2013; 28(3): 131-136
[Pubmed]  [Google Scholar]
2 Effects of botulinum toxin type a on quality of life assessed with the WHOQOL-BREF in hemifacial spasm and blepharospasm
Gürsoy, A.E. and Ugurad, I. and Babacan-Yildiz, G. and Kolukisa, M. and Çelebi, A.
Neurology Psychiatry and Brain Research. 2013; 19(1): 12-18
[Pubmed]  [Google Scholar]
3 Efficacy of botulinum toxin injections in the treatment of various types of facial region disorders [Yüz bölgesi hastaliklarinin çeşitli tiplerinde botulinum toksini enjeksiyonlarinin etkinliǧi]
Joban, A. and Matur, Z. and Hanaǧasi, H.A. and Parman, Y.
Turk Noroloji Dergisi. 2012; 18(4): 133-161
[Pubmed]  [Google Scholar]
4 Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia [Influência da toxina botulínica tipo A na função lacrimal de pacientes com distonias faciais]
de Oliveira, F.C. and de Oliveira, G.C. and Cariello, A.J. and Felberg, S. and Osaki, M.H.
Arquivos Brasileiros de Oftalmologia. 2010; 73(5): 405-408
[Pubmed]  [Google Scholar]
5 Botulinum toxin type A in the treatment of hemifacial spasm: An 11-year experience [Toxina botulínica tipo A no tratamento do espasmo hemifacial: 11 anos de experiência]
Barbosa, E.R. and Takada, L.T. and Gonçalves, L.R. and Costa, R.M.P.N. and Silveira-Moriyama, L. and Chien, H.F.
Arquivos de Neuro-Psiquiatria. 2010; 68(4): 502-505
[Pubmed]  [Google Scholar]
6 The effects of botulinum toxin a on ephaptic transmission in idiopathic hemifacial spasm
Kurt, T. and Seçil, Y. and Gürgör, N. and Tokuçoǧlu, F. and Beckmann, Y. and Ertekin, C.
International Journal of Neuroscience. 2009; 119(11): 2044-2055
[Pubmed]  [Google Scholar]
7 Fifteen-Year Experience in Treating Blepharospasm with Botox or Dysport: Same Toxin, Two Drugs
Bentivoglio, A.R. and Fasano, A. and Ialongo, T. and Soleti, F. and Lo Fermo, S. and Albanese, A.
Neurotoxicity Research. 2009; 15(3): 224-231
[Pubmed]  [Google Scholar]
8 Relationship between various clinical outcome assessments in patients with blepharospasm
Jankovic, J. and Kenney, C. and Grafe, S. and Goertelmeyer, R. and Comes, G.
Movement Disorders. 2009; 24(3): 407-413
[Pubmed]  [Google Scholar]
9 Efficacy and safety of purified botulinum toxin type A (Dysport®) for the treatment of benign essential blepharospasm: A randomized, placebo-controlled, phase II trial
Truong, D. and Comella, C. and Fernandez, H.H. and Ondo, W.G.
Parkinsonism and Related Disorders. 2008; 14(5): 407-414
[Pubmed]  [Google Scholar]
10 Essential blepharospasm and hemifacial spasm: Characteristic of the patient, botulinum toxin A treatment and literature review [Blefarospasmo essencial e espasmo hemifacial: Características dos pacientes, tratamento com toxina botulínica A e revisão da literatura]
Schellini, S.A. and Matai, O. and Igami, T.Z. and Padovani, C.R. and Padovani, C.P.
Arquivos Brasileiros de Oftalmologia. 2006; 69(1): 23-26
[Pubmed]  [Google Scholar]

 

Online since 20th March '04
Published by Wolters Kluwer - Medknow